Monday, October 25, 2021
HomeLatest NewsQuality/Safety NewsHHS Moves to Reduce Administrative Procedural Barriers to OUD Treatment

HHS Moves to Reduce Administrative Procedural Barriers to OUD Treatment

Physicians registered with the Drug Enforcement Administration will no longer need to meet the X-waiver requirement to prescribe treatments such as buprenorphine for opioid use disorder (OUD), U.S. Department of Health and Human Services (HHS) recently announced. HHS said it will publish updates to its Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that expands access to medication-assisted treatment by exempting physicians from certain certification requirements.

The new policy potentially limits physicians to treating no more than 30 patients with buprenorphine for OUD at any single time. The HSS will make exceptions to this limit for hospital-based physicians, such as those working in emergency departments.

For more information on this policy, click here.

Stay Connected

Unified Voice Newsletter

Events This Month

october

26oct10:00 am12:00 pmSDAHO District III Fall Meeting10:00 am - 12:00 pm CST Event Type :District Meeting

26oct11:00 am12:00 pmEnd of Life series: Loss, Grief & Bereavement (Part 2)Webinar11:00 am - 12:00 pm CST Event Type :Education Events,Webinar

27oct1:00 pm2:30 pmCouncil Meeting: Clinical and Quality Integration1:00 pm - 2:30 pm CST Event Type :Board & Council Meeting

X


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact